AzTrials
AzTrials

Radial Artery OcclusionRADIUSNCT07614386

Radial Access Data in Vascular Interventions Registry

An observational study of Radial Artery Occlusion and Radial Artery Spasm, run by Mersin Medicalpark Hastanesi at 1 site in Turkey (Türkiye).

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record

Search all trials

Trial summary

The RADIUS study is a prospective observational registry designed to collect real-world data regarding radial and ulnar artery access in percutaneous vascular interventions. The study aims to evaluate procedural characteristics, access-site complications, procedural success, and short-term clinical outcomes associated… Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
Radial and Ulnar Artery Access
Type of treatment
Surgery or procedure
How many people
20,000 participants
Where
1 siteTurkey (Türkiye)
Study dates
15 May 2026to 20 May 2031
How long will I take part?
1 Year
Phase
Observational

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Adult patients undergoing routine percutaneous vascular interventions via radial or ulnar artery access.

Who may be able to join

  • Age ≥18 years
  • Patients undergoing routine percutaneous vascular interventions via radial or ulnar artery access
  • Ability to provide informed consent

Who cannot join

  • Age <18 years
  • Procedures performed without radial or ulnar artery access
  • Incomplete procedural or clinical data
  • Refusal to participate in the registry

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Turkey (Türkiye)1 site, 1 recruiting
  • Mersin Medicalpark hospital

    Mersin, Mezitli, 33010

    Sefa Sural, MD, +905325650160, sesural@hotmail.com

    Gökhan AVCI, MD, drgavci@gmail.com

    Recruiting

Other trials in Turkey (Türkiye)

About this study

Official title: Radial Access Data in Vascular Interventions: A Prospective Observational Registry Study

The RADIUS study is a prospective observational registry designed to collect real-world data regarding radial and ulnar artery access in percutaneous vascular interventions. The study aims to evaluate procedural characteristics, access-site complications, procedural success, and short-term clinical outcomes associated with transradial and transulnar vascular access.

Patients undergoing routine percutaneous vascular interventions via radial or ulnar artery access at Mersin Medical Park Hospital will be consecutively enrolled. Demographic, clinical, angiographic, procedural, and post-procedural data will be prospectively collected and analyzed.

Read more

The study was initially designed as a single-center registry; however, following Institutional Review Board (IRB) approval, expansion into a multicenter registry with participating centers is planned.

This study is observational in nature and does not involve any experimental treatment, device, or intervention beyond standard clinical care.

Read the detailed description

The RADIUS (Radial Access Data in Vascular Interventions) study is a prospective observational registry designed to systematically collect real-world data regarding radial and ulnar artery access in percutaneous vascular interventions.

Transradial access has become increasingly preferred in contemporary interventional practice because of lower bleeding risk, improved patient comfort, earlier mobilization, and reduced vascular complications compared with traditional femoral access. In addition, transulnar access has emerged as an alternative vascular access strategy in selected patients. Despite the increasing adoption of radial and ulnar access techniques, comprehensive real-world registry data evaluating procedural characteristics, vascular complications, procedural success, and clinical outcomes remain limited.

The RADIUS registry aims to evaluate demographic, clinical, angiographic, procedural, and post-procedural characteristics of patients undergoing percutaneous vascular interventions through radial or ulnar artery access. Particular focus will be placed on access-site complications, including radial artery spasm, radial artery occlusion, bleeding complications, crossover to alternative access sites, vascular injury, and short-term clinical outcomes.

The study will enroll consecutive adult patients undergoing routine percutaneous vascular interventions via radial or ulnar artery access at Mersin Medical Park Hospital between May 2026 and May 2031. Data will be prospectively collected from procedural reports, hospital electronic medical records, and routine clinical evaluations.

Collected variables will include demographic characteristics, cardiovascular risk factors, comorbidities, laboratory findings, angiographic and procedural details, vascular access characteristics, procedural duration, fluoroscopy time, contrast volume, devices and techniques used during procedures, procedural success rates, and in-hospital and short-term complications.

The study was initially designed as a single-center registry; however, expansion into a multicenter registry involving additional participating centers is planned following Institutional Review Board (IRB) approval and local regulatory processes.

This registry is purely observational in nature and does not involve any experimental drug, device, or intervention beyond standard clinical care. All procedures and treatment strategies will be performed according to current routine clinical practice and operator discretion.

Data obtained from the registry will be analyzed using appropriate statistical methods, and the results are expected to contribute to the understanding and optimization of radial and ulnar access strategies in vascular interventions and support future scientific publications.

Being tested
Radial and Ulnar Artery Access
Keywords
Radial access, Ulnar access, Transradial intervention, Coronary angiography, Percutaneous coronary intervention, Vascular complications, Radial artery occlusion, Radial Artery Spasm, Registry
Medical subject headings
Arterial Occlusive Diseases, Coronary Artery Disease, Peripheral Arterial Disease

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Radial and Ulnar Artery AccessProcedure or surgery

    Routine percutaneous vascular interventions performed via radial or ulnar artery access according to standard clinical practice.

Study groups in NCT07614386
Study groupRoleWhat they receive
Radial and Ulnar Access Registry CohortPatients undergoing routine percutaneous vascular interventions via radial or ulnar artery access.
Receives: Procedure: Radial and Ulnar Artery Access

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Radial Artery Occlusion Rate

    Incidence of radial artery occlusion following percutaneous vascular interventions performed via radial artery access.

    Measured: Within 1 year after procedure

  2. Access-Site Vascular Complication Rate

    Incidence of vascular access-site complications including bleeding, hematoma, pseudoaneurysm, arterial dissection, and vascular injury.

    Measured: through study completion, an average of 1 year

  3. Radial Artery Spasm Rate

    Incidence of clinically significant radial artery spasm during or immediately after the procedure.

    Measured: During Procedure

Secondary outcomes (6)
  1. Procedural Success Rate

    Successful completion of the planned vascular intervention using radial or ulnar artery access without crossover to alternative access.

    Measured: During procedure

  2. Crossover Rate

    Need for conversion from radial or ulnar access to another vascular access site during the procedure.

    Measured: During Procedure

  3. Bleeding Complications

    Incidence of access-site or non-access-site bleeding complications following the procedure.

    Measured: During Procedure

  4. Fluoroscopy Time

    Total fluoroscopy time during the procedure, measured in minutes.

    Measured: During Procedure

  5. Length of Hospital Stay

    Duration of hospitalization following vascular intervention, measured in days from the date of the procedure until hospital discharge.

    Measured: From the date of vascular intervention until hospital discharge, assessed up to 30 days

  6. Contrast Volume

    Total volume of contrast agent administered during the procedure, measured in milliliters (mL).

    Measured: During Procedure

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 May 2026
  2. Study start15 May 2026
  3. Primary completion31 Dec 2030 (estimated)
  4. Study completion20 May 2031 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
20,000 participants (estimated)
Target duration
1 Year
IDs, dates and publications
ClinicalTrials.gov ID
NCT07614386
Sponsor's protocol ID
SRL-RADIUS-001
Acronym
RADIUS
Status last verified
Jun 2026
First submitted
15 May 2026
Last updated
23 Jun 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: There is no plan to make individual participant data (IPD) publicly available.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in